ESC

Experts Discuss Non-Responders to CRT and AF Ablation

EPIC Alliance experts at the European Society of Cardiology (ESC) congress presented original research and real-world clinical evidence on non-responders to cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) ablation.

EPIC Alliance physicians at ESC 2016.
EPIC Alliance physicians at ESC 2016.
Source: BIOTRONIK

The all-women panel of physicians from the EPIC Alliance, an initiative promoting female electrophysiologists (EPs), spoke on how to support patients who do not respond to treatment at the symposium “Breaking the Non-Response Barrier: CRT and AF Ablation”.

Both CRT and AF ablation can be life-saving, but despite major technological breakthroughs, and a broader understanding of the pathophysiology, the success rates of both procedures plateau at about 70 percent.1,2 The reasons for this remains largely unknown, but ongoing studies such as BIOWOMEN are investigating which patients best respond to CRT therapy.

Dr. Mina Chung, Cleveland Clinic, US, kicked off the symposium with an overview of the latest findings in CRT trials. She was followed by Dr. Gemma Pelargonio, Catholic University of the Sacred Heart, Rome, Italy, who explored using CRT in heart failure patients with “narrow” QRS complexes. Dr. Claudia Herrera-Siklody, Ludwigsburg Clinic, Germany, discussed strategies to treat persistent AF, and Dr. Isabella Deisenhofer, German Heart Centre, Munich, ended the symposium by weighing the risks and benefits of AF ablation.

”Pushing success rates for CRT and AF ablation will require a greater understanding of the clinical barriers and novel technologies, and this symposium highlighted that significant issue,” commented Dr. Sabine Ernst, Royal Brompton and Harefield Hospital, London, UK, who co-chaired the session. Speaking about the EPIC Alliance she added: “The EPIC Alliance is a global network of women in EP supporting women to choose EP as a career option and to reach their full potential. One way we can do that is to feature them as speakers at prominent symposia such as the ESC Congress.”


References
1 Daubert C et al. European Heart Journal. July 2016.
2 Bottoni N et al. Europace. 2015, 17.

Source: BIOTRONIK

01.09.2016

Read all latest stories

Related articles

Photo

Tissue model

How clots become firm in the presence of blood flow

Blood clotting is one of the most critical, protective processes in human physiology. When something goes wrong with clotting, either because there is too much clotting, leading to a stroke, or not…

Photo

Micro-constrictions

Reducing damage after a heart attack

Researchers in the Medical Sciences Division of Oxford University have established a key cause of micro blood vessels constricting during surgery to reopen a blocked artery, and identified a…

Photo

Simplified catheter ablation

“Back to basics” atrial fibrillation procedure could cut waiting lists

A day case catheter ablation procedure which includes only the bare essentials and delivers the same outcomes could slash waiting lists for atrial fibrillation patients, according to late-breaking…

Related products

Quart – DSA Test Phantom

Testing Devices

Quart – DSA Test Phantom

QUART GmbH